A sound approach: Hydroxychloroquine reduces mortality in severe COVID-19

被引：0
|
作者：
Zervos, Marcus [1 ,2 ]
Arshad, Samia [1 ]
Kilgore, Paul [2 ,3 ]
Chaudhry, Zohra S. [1 ]
Jacobsen, Gordon [4 ]
Wang, Dee Dee [5 ]
Huitsing, Kylie [1 ,2 ]
Brar, Indira [1 ,2 ]
Alangaden, George J. [1 ]
Ramesh, Mayur S. [1 ]
McKinnon, John E. [1 ]
O'Neill, William [5 ]
机构：
[1] Henry Ford Hosp, Infect Dis, Detroit, MI 48202 USA
[2] Wayne State Univ, Sch Med, Detroit, MI USA
[3] Wayne State Univ, Eugene Applebaum Coll Pharm, Detroit, MI USA
[4] Henry Ford Hosp, Publ Hlth Sci, Detroit, MI 48202 USA
[5] Henry Ford Hosp, Div Cardiovasc Dis & Struct Heart, Detroit, MI 48202 USA
来源：
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES | 2020年 / 99卷
关键词：
D O I：
10.1016/j.ijid.2020.07.059
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：138 / 139
页数：2
相关论文
共 50 条
  • [31] Impact of tocilizumab administration on mortality in severe COVID-19
    Andrew Tsai
    Oumou Diawara
    Ronald G. Nahass
    Luigi Brunetti
    Scientific Reports, 10
  • [32] Hydroxychloroquine and azithromycin as a treatment of COVID-19
    Alice Fanin
    Jessica Calegari
    Anna Beverina
    Silvia Tiraboschi
    Internal and Emergency Medicine, 2020, 15 : 841 - 843
  • [33] Is hydroxychloroquine beneficial for COVID-19 patients?
    Xing Li
    Ying Wang
    Patrizia Agostinis
    Arnold Rabson
    Gerry Melino
    Ernesto Carafoli
    Yufang Shi
    Erwei Sun
    Cell Death & Disease, 11
  • [34] Tocilizumab could reduce Mortality in severe COVID-19
    Ruchalla, Elke
    PNEUMOLOGIE, 2021, 75 (05):
  • [35] MYOCARDIAL INJURY IS NOT ASSOCIATED WITH MORTALITY IN SEVERE COVID-19
    O'Brien, Connor G.
    Ashland, Melanie
    Chang, Donald D.
    Morin, Daniel P.
    Kapil, Shikha
    Barnett, Christopher F.
    Khanijo, Sameer
    Stavi, Dekel
    Goffi, Alberto
    Fiza, Babar
    Patterson, Andrew
    Carrier, Francois Martin
    Daubert, Thomas
    Castellucci, Clara
    Thompson, Shaun
    Bughrara, Nibras
    Zekhtser, Mitchell
    Courchesne, Karl
    Mayette, Michael
    Parikh, Rushi
    Mohabir, Paul
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 641 - 641
  • [36] Hydroxychloroquine as Prophylaxis for COVID-19: A Review
    Monti, Manuela
    Vertogen, Bernadette
    Masini, Carla
    Donati, Caterina
    Lilli, Claudia
    Zingaretti, Chiara
    Musuraca, Gerardo
    De Giorgi, Ugo
    Cerchione, Claudio
    Farolfi, Alberto
    Cortesi, Pietro
    Viale, Pierluigi
    Martinelli, Giovanni
    Nanni, Oriana
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [37] Hydroxychloroquine, TTP, COVID-19, and SLE
    Sookaromdee, Pathum
    Wiwanitkit, Viroj
    TURKISH JOURNAL OF HEMATOLOGY, 2021, 38 (01) : 99 - 99
  • [38] Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients: authors' response
    Fiolet, Thibault
    Guihur, Anthony
    Rebeaud, Mathieu Edouard
    Mulot, Matthieu
    Peiffer-Smadja, Nathan
    Mahamat-Saleh, Yahya
    CLINICAL MICROBIOLOGY AND INFECTION, 2021, 27 (01) : 138 - 140
  • [39] The strange case of hydroxychloroquine and COVID-19
    Sciatti, Edoardo
    Ceconi, Claudio
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2022, 28 (17) : 1873 - 1874
  • [40] Chloroquine or hydroxychloroquine for prophylaxis of COVID-19
    Principi, Nicola
    Esposito, Susanna
    LANCET INFECTIOUS DISEASES, 2020, 20 (10) : 1118 - 1118
12345